King Pharmaceuticals - M&A Summary, Ownership, and Business Overview

Life ScienceCompany

King Pharmaceuticals M&A Summary

King Pharmaceuticals has acquired 2 companies of its own.

King Pharmaceuticals’ largest acquisition to date was in 2008, when it acquired Alpharma Pharmaceuticals for $16.0B. King Pharmaceuticals has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

King Pharmaceuticals Ownership

Who owns King Pharmaceuticals?

King Pharmaceuticals is owned by Pfizer. It was acquired on March 1, 2011.

King Pharmaceuticals Business Overview

Where is King Pharmaceuticals headquartered?

King Pharmaceuticals is headquartered in Bristol, Tennessee.

How many employees does King Pharmaceuticals have?

King Pharmaceuticals has 2,600 employees.

What sector is King Pharmaceuticals in?

King Pharmaceuticals is a life science company.

When was King Pharmaceuticals founded?

King Pharmaceuticals was founded in 1993.

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity2
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Advisors 2

King Pharmaceuticals LLC

501 Fifth Street,
Bristol, Tennessee 37620
United States,
(423) 989-8000
www.kingpharm.com

King Pharmaceuticals LLC is a vertically integrated branded pharmaceutical company. King seeks to capitalize on opportunities in the pharmaceutical industry through the development, including through in-licensing arrangements and acquisitions, of novel branded prescription pharmaceutical products and technologies that complement the Company's focus in specialty-driven markets, particularly neuroscience and hospital. King's wholly owned subsidiary, Alpharma, LLC, is also a leader in the development, registration, manufacture and marketing of pharmaceutical products for food producing animals.


M&A Summary

Buy vs Sell

Year ≤ '03 '04 '05 '06 '07 '08 T
Buy (0.4/yr) # - - - - - 2 2
vol $17.6B $17.6B
Sell (0.0/yr) # - - - - - - 0
  2

Most Recent M&A

Company Date Value Type
Alpharma Pharmaceuticals Inc. 2008-12-29 16.0B USD Add-on Acquisition
Piscataway, New Jersey
Alpharma, Inc. 2008-11-21 1.6B USD Add-on Acquisition
Piscataway, New Jersey
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 2 (100%) 17.6B (100%) - -
Total 2 $17.6B - -

By Geo

State/Country Buy Value Sell Value
United States 2 17.6B - -
  New Jersey 2 17.6B - -
Total 2 $17.6B - -

Top M&A Advisors

Financial Deals
Credit Suisse Investment Banking
2
Legal Deals
Dewey & LeBoeuf LLP
1

Deal Values

buy # Total
> $1B 2 $17.6B
TOTAL $17.6B
Largest Alpharma Pharmaceuticals Inc.
$16.0B (2008-12-29)

 Subscribe to unlock this and 204,477
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 196K M&A Transactions
  • 200K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 78K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.